Skip to content

Implementation of a Primary Hospital Provider (PHP) Team

Implementation of a Primary Hospitalist Provider Team to Enhance the Care for High-Need High-Complexity Patients Requiring Hospitalization

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06581224
Acronym
PHP Team
Enrollment
1200
Registered
2024-09-03
Start date
2025-01-09
Completion date
2028-01-01
Last updated
2026-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High-need, High-complexity

Brief summary

The goal of this pragmatic clinical trial is to learn if it is possible to implement a Primary Hospital Provider (PHP) team that aims to improve continuity of care for patients who are frequently hospitalized. The main question it aims to answer is: Are patients assigned to the PHP team more likely to be assigned to this team during a follow up hospitalization? Researchers will compare this to similar patients assigned to receive usual care. Some patient participants (or their caregivers) from both the PHP team and usual care groups will be asked to participate in interviews to help researchers understand the needs of patients who are frequently admitted and the care they receive.

Detailed description

The overarching goal of this study is to reduce inpatient care fragmentation for high-need, high-complexity (HNHC) patients and improve outcomes by implementing a primary hospital provider (PHP) team. In this study, we will specifically evaluate the feasibility of implementation of this team as well as workforce and operational acceptance, as well as its impact on continuity of hospital medicine care across subsequent admissions. The study is conducted as a two-arm, pragmatic hybrid type II effectiveness implementation trial with two sequential phases. Phase 1 focuses on initial feasibility and early acceptability of the PHP team. Phase 2 evaluates sustained implementation, reach, and longitudinal continuity outcomes using the same intervention, eligibility criteria, and study procedures. No changes will be made to the intervention, eligibility criteria, or data collection methods between phases. Study Aims: Aim 1 Primary Implementation Objective: Compare the fragmentation in hospital medicine care during subsequent admissions for HNHC patients assigned to the PHP team with those continuing to receive usual care. * Aim 1a (Phase 1): Assess feasibility and early continuity of care during subsequent admissions. * Aim 1b (Phase 2): Evaluate sustained continuity and re-exposure to the PHP team across repeated hospitalizations over an extended enrollment period. Aim 2 Primary Exploratory Objective: Explore perceptions of care among HNHC patients and caregivers randomized to the PHP team and to a usual care team. Aim 3 Secondary Exploratory Objective: Identify operational perceptions of the implementation of the PHP team from a workforce and system-level perspective.

Interventions

OTHERPrimary Hospital Provider Team

The PHP team aims to enhance continuity during hospital readmissions with a consistent cohort of seven hospital medicine physicians and two advanced practice providers (APPs). To improve care transitions, the team will have an integrated case manager who will continue following PHP patients during subsequent hospitalizations. Physicians will follow a standard seven-day service schedule, with the two APPs alternating five-to-seven-day periods. Daily huddles between physicians and APPs will further promote continuity. During the index admission, the PHP team will create a care plan in consultation with the patient to improve standardization of inpatient care and transition to outpatient settings. Communication will be a core tenet of the team, with scheduled monthly team meetings of physicians, APPs, case manager, dyad partner, and representatives from nursing and therapy services to revise individualized care plans for PHP patients and brainstorm solutions for complex challenges.

Sponsors

University of Wisconsin, Madison
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age greater than 18 at the time of index admission * Two or more hospitalizations to a general medicine service at UW Health (University Hospital or East Madison Hospital) within the past 12 months AND an EPIC Readmission Risk Score of greater than a predetermined value

Exclusion criteria

* Outpatient primary care provider is part of the UW Health Family Medicine service that currently admits their own patients to a separate service at University Hospital * Patients with an oncologic diagnosis for which they are actively receiving chemotherapy or immunotherapy * Incarcerated persons * Pregnant women

Design outcomes

Primary

MeasureTime frameDescription
Number of patients readmitted to the PHP teamImplementation Phase 1 up to 9 months, Sustained Implementation Phase 2 up to 33 monthsThe number of patients in the PHP arm who were readmitted to the PHP team on subsequent hospitalizations.
Number of patients readmitted to usual care teamImplementation Phase 1 up to 9 months, Sustained Implementation Phase 2 up to 33 monthsThe number of patients in the usual care arm who were readmitted to a usual care team on subsequent hospitalizations.
Percentage of patients readmitted to the PHP teamImplementation Phase 1 up to 9 months, Sustained Implementation Phase 2 up to 33 monthsThe percentage of patients in the PHP arm who were readmitted to the PHP team on subsequent hospitalizations.
Percentage of patients readmitted to usual care teamImplementation Phase 1 up to 9 months, Sustained Implementation Phase 2 up to 33 monthsThe percentage of patients in the usual care arm who were readmitted to a usual care team on subsequent hospitalizations.

Countries

United States

Contacts

CONTACTSara Westergaard, MD, MPH
swesterga@medicine.wisc.edu608-261-1150
PRINCIPAL_INVESTIGATORSara Westergaard, MD, MPH

University of Wisconsin, Madison

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026